Probucol modulates iron nitrilotriacetate (Fe-NTA)-dependent renal carcinogenesis and hyperproliferative response: diminution of oxidative stress
Tóm tắt
Từ khóa
Tài liệu tham khảo
Cancer facts and figures (1997) American Cancer Society, Inc
Birt DF, Pelling JC, Nair S et al (1996) Diet intervention for modifying cancer risk. Prog Clin Biol Res 395:223–234
Morse MA, Stoner GD (1993) Cancer chemoprevention: principles and prospects. Carcinogenesis 14:1737–1746
Okada S, Midorikawa O (1982) Induction of rat renal adenocarcinoma by ferric nitrilotriacetate. Jpn Arch Int Med 29:485–491
Mizuno R, Kawabata T, Sutoh Y et al (2006) Oxidative renal tubular injuries induced by aminocarboxylate–type iron (III) coordination compounds as candidate renal carcinogens. Biometals 19:675–683
Awai M, Nagasaki M, Yamanoi Y et al (1979) Induction of diabetes in animals by parenteral administration of ferric nitrilotriacetate. A model of experimental haemochromatosis. Am J Pathol 95:663–672
Aruoma OI, Halliwell B, Gajewski E et al (1989) Damage to the bases in DNA induced by hydrogen peroxide and ferric ion chelates. J Biol Chem 24:20509–20512
Toyokuni S, Uchida K, Okamoto K et al (1994) Formation of 4-hydroxy-2-nonenal-modified proteins in renal proximal tubules of rats treated with renal carcinogen. Proc Natl Acad Sci USA 91:2616–2620
Athar M, Iqbal M (1998) Ferric nitrilotriacetate promotes N-diethyl nitrosoamine-induced renal tumorigenesis in rat: implications for the involvement of oxidative stress. Carcinogenesis 19:1133–1139
Iqbal M, Giri U, Athar M (1995) Ferric nitrilotriacetate is a potent hepatic tumor promoter and acts through the generation of oxidative stress. Biochem Biophys Res Commun 212:557–563
Iqbal M, Sharma SD, Rahman A et al (1999) Evidence that ferric nitrilotriacetate mediates oxidative stress by down-regulating DT-diaphorase activity: implications for carcinogenesis. Cancer Lett 141:151–157
Iqbal M, Giri U, Giri DK et al (1997) Evidence that Fe-NTA induced renal prostaglandin F2∝ is responsible for hyperplastic response in kidney implications for the role of cyclooxygenase-dependent arachidonic acid metabolism in renal tumor promotion. Biochem Mol Biol Intl 42:1115–1124
Iqbal M, Giri U, Giri DK et al (1999) Age dependent renal accumulation of 4-hydroxy-2-nonenal (HNE)-modified proteins following parenteral administration of ferric nitrilotriacetate commensurate with its differential toxicity: implications for the involvement of HNE-protein adducts in oxidative stress and carcinogenesis. Arch Biochem Biophys 365:101–112
Wissler A, Vesselinovitch D (1983) Combined effects of cholestyramine and probucol on regression of atherosclerosis in Rhesus monkey aortas. Appl Pathol 1:89–96
Yamamoto A, Matsuzawa Y, Yokoyama S et al (1986) Effects of probucol on xanthoma regression in familial hypercholesterolemia. Am J Cardiol 57:29H–35H
Bridges AB, Scott NA, Belch JJF (1991) Probucol, a superoxide free radical scavenger in vitro. Atherosclerosis 89: 263–265
Hiramatsu M, Liu J, Edamatsu R et al (1994) Probucol scavenged 1,1-diphenyl-2-picrylhydrazyl radicals and inhibited formation of thiobarbituric acid reactive substances. Free Radic Biol Med 16:201–206
Dujovne AC, Harris WS, Colle Gerrond LL et al (1994) Comparison of effects of probucol versus vitamin E on ex vivo oxidation susceptibility of lipoproteins in hyperlipoproteinemia. Am J Cardiol 74:38–42
Gotoh N, Shimizu K, Komuro E et al (1992) Antioxidation activities of probucol against lipid peroxidation. Biochim Biophys Acta 1128:147–154
Kuzuya M, Kuzuya F (1993) Probucol as an antioxidant and antiatherogenic drug. Free Radic Biol Med 14:67–77
Bird JE, Milhoan K, Wilson CB et al (1988) Ischemic acute renal failure and antioxidant therapy in rat. The relation between glomerular and tubular dysfunction. J Clin Invest 81:1630–1638
Dage RC, Anderson BA, Mao SJ et al (1991) Probucol reduced myocardial dysfunction during reperfusion after short-term ischemia in rabbit heart. J Cardiovas Pharmacol 17:158–165
Iqbal M, Okada S (2003) Induction of NAD(P)H:quinone reductase by probucol: a possible mechanism for protection against chemical carcinogenesis and toxicity. Pharmacol Toxicol 93:259–263
Iqbal M, Sharma SD, Okada S (2004) Probucol as a potent inhibitor of oxygen radical induced lipid peroxidation and DNA damage: in vitro studies. Redox Rep 9:167–172
Mohandas J, Marshall JJ, Duggin GG et al (1984) Differential distribution of glutathione and glutathione related enzymes in rabbit kidney: possible implications in analgesic neuropathy. Cancer Res 44:5086–5091
Jollow DJ, Mitchell JR, Zampagilone N et al (1974) Bromobenzene-induced liver necrosis: protective role of glutathione and evidence for 3,4-bromobenzene oxides as a hepatotoxic intermediate. Pharmacology 11:151–169
Buege JA, Aust SD (1978) Microsomal lipid peroxidation. In: Packer L (ed) Methods in enzymology, vol 52, Academic Press, NJ, pp 302–310
O’Brien TG, Simsiman RC, Boutwell RK (1975) Induction of the polyamine biosynthetic enzymes in mouse epidermis by tumor promoting agents. Cancer Res 35:1662–1670
Zaheer N, Tiwari KK, Krishnan PS (1965) Exposure and solubilization of hepatic mitochondrial shunt dehydrogenase. Arch Biochem Biophys 109:646–648
Claiborne A (1985) Catalase activity. In: Green Wald RA (ed) CRC handbook of methods for oxygen radical research. CRC Press, Boca Raton, FL, pp 283–284
Habig WH, Pabst MJ, Jokoby WB (1974) Glutathione S-transferase: the first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130–7139
Benson AM, Hunkeler AJ, Talalay P (1980) Increase of NADPH: quinone reductase activity by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. Proc Natl Acad Sci USA 77:5216–5220
Agarwal R, Mukhtar H (1991) Cutaneous chemical carcinogenesis. In: Mukhtar H (ed) Pharmacology of skin. CRC Press, Boca Raton, FL, pp 371–387
Ames BN, Gold LS, Willett WC (1995) The cause and prevention of cancer. Proc Natl Acad Sci USA 92:5258–5265
Kensler TW, Taffe BG (1989) Role of free radicals in tumor promotion and progression. Prog Clin Biol Res 298:233–248
Perchellet JP, Perchellet EM (1989) Antioxidants and multistage carcinogenesis in mouse skin. Free Radic Biol Med 7:377–408
El-Demerdash E, El-Denshary E, El-Didi M (2002) Probucol and liver efficiency during chemically-induced hepatocarcinogenesis. Anticancer Res 22:977–984
Zarkovic M, Qin X, Nakatsuru Y et al (1995) Inhibitory effect of probucol on benzo[a]pyrene induced lung tumorigenesis. Carcinogenesis 16:2599–2601
Nishimura G, Yanoma S, Mizuno H et al (1999) An antioxidant, probucol, induces anti-angiogenesis and apoptosis in athymic nude mouse xenografted human head and neck squamous carcinoma cells. Jpn J Cancer Res 90:1224–1230
Qin X, Zhang S, Zarkovic M et al (1995) Inhibitory effect of probucol on nephrotoxicity induced by ferric nitrilotriacetate in rats. Carcinogenesis 16:2549–2552
Haklar G, Sirikci O, Ozer NK et al (1998) Measurement of reactive oxygen species by chemiluminescence in diet-induced atherosclerosis: protective roles of vitamin E and probucol on different radical species. Int J Clin Lab Res 28:122–126